Malonyl-CoA decarboxylase deficiency

Revision as of 17:10, 9 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Malonyl-CoA decarboxylase deficiency
Error creating thumbnail: File missing
Malonyl-CoA
OMIM 248360
DiseasesDB 33804

WikiDoc Resources for Malonyl-CoA decarboxylase deficiency

Articles

Most recent articles on Malonyl-CoA decarboxylase deficiency

Most cited articles on Malonyl-CoA decarboxylase deficiency

Review articles on Malonyl-CoA decarboxylase deficiency

Articles on Malonyl-CoA decarboxylase deficiency in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Malonyl-CoA decarboxylase deficiency

Images of Malonyl-CoA decarboxylase deficiency

Photos of Malonyl-CoA decarboxylase deficiency

Podcasts & MP3s on Malonyl-CoA decarboxylase deficiency

Videos on Malonyl-CoA decarboxylase deficiency

Evidence Based Medicine

Cochrane Collaboration on Malonyl-CoA decarboxylase deficiency

Bandolier on Malonyl-CoA decarboxylase deficiency

TRIP on Malonyl-CoA decarboxylase deficiency

Clinical Trials

Ongoing Trials on Malonyl-CoA decarboxylase deficiency at Clinical Trials.gov

Trial results on Malonyl-CoA decarboxylase deficiency

Clinical Trials on Malonyl-CoA decarboxylase deficiency at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Malonyl-CoA decarboxylase deficiency

NICE Guidance on Malonyl-CoA decarboxylase deficiency

NHS PRODIGY Guidance

FDA on Malonyl-CoA decarboxylase deficiency

CDC on Malonyl-CoA decarboxylase deficiency

Books

Books on Malonyl-CoA decarboxylase deficiency

News

Malonyl-CoA decarboxylase deficiency in the news

Be alerted to news on Malonyl-CoA decarboxylase deficiency

News trends on Malonyl-CoA decarboxylase deficiency

Commentary

Blogs on Malonyl-CoA decarboxylase deficiency

Definitions

Definitions of Malonyl-CoA decarboxylase deficiency

Patient Resources / Community

Patient resources on Malonyl-CoA decarboxylase deficiency

Discussion groups on Malonyl-CoA decarboxylase deficiency

Patient Handouts on Malonyl-CoA decarboxylase deficiency

Directions to Hospitals Treating Malonyl-CoA decarboxylase deficiency

Risk calculators and risk factors for Malonyl-CoA decarboxylase deficiency

Healthcare Provider Resources

Symptoms of Malonyl-CoA decarboxylase deficiency

Causes & Risk Factors for Malonyl-CoA decarboxylase deficiency

Diagnostic studies for Malonyl-CoA decarboxylase deficiency

Treatment of Malonyl-CoA decarboxylase deficiency

Continuing Medical Education (CME)

CME Programs on Malonyl-CoA decarboxylase deficiency

International

Malonyl-CoA decarboxylase deficiency en Espanol

Malonyl-CoA decarboxylase deficiency en Francais

Business

Malonyl-CoA decarboxylase deficiency in the Marketplace

Patents on Malonyl-CoA decarboxylase deficiency

Experimental / Informatics

List of terms related to Malonyl-CoA decarboxylase deficiency


Malonyl-CoA decarboxylase deficiency (or Malonic aciduria) is an autosomal recessive metabolic disorder caused by a genetic mutation which disrupts the activity of Malonyl-Coa decarboxylase. This enzyme breaks down Malonyl-CoA (a fatty acid precursor and a fatty acid oxidation blocker) into Acetyl-CoA and carbon dioxide.

Diagnosis

Without the enzymatic activity of Malonyl-CoA decarboxylase, cellular Mal-CoA increases so dramatically that at the end it is instead broken down by an unspecific short-chain acyl-CoA hydrolase which produces malonic acid and CoA. Malonic acid is a krebs cycle inhibitor preventing the cells to make ATP through oxidation.

In this condition, the cells, to make ATP, are forced to increase glycolysis which produces lactic acid as a by-product. The increase of lactic and malonic acid drastically lowers blood pH, and causes both lactic and malonic aciduria (acidic urine).

The signs and symptoms of this disorder typically appear in early childhood. Almost all affected children have delayed development. Additional signs and symptoms can include weak muscle tone (hypotonia), seizures, diarrhea, vomiting, and low blood sugar (hypoglycemia). A heart condition called cardiomyopathy, which weakens and enlarges the heart muscle, is another common feature of malonyl-CoA decarboxylase deficiency. This condition is very rare, as fewer than 20 cases have been reported.

Pathophysiology

Malonyl-CoA decarboxylase deficiency has an autosomal recessive pattern of inheritance.

Mutations in the MLYCD gene cause malonyl-CoA decarboxylase deficiency. The MLYCD gene provides instructions for making an enzyme called malonyl-CoA decarboxylase. Within cells, this enzyme helps regulate the formation and breakdown of a certain group of fats called fatty acids.

Many tissues, including heart muscle, use fatty acids as a major source of energy. Mutations in the MLYCD gene reduce or eliminate the function of malonyl-CoA decarboxylase. A lack of this enzyme disrupts the normal balance of fatty acid formation and breakdown. As a result, fatty acids cannot be converted to energy, which can lead to characteristic features of this disorder such as low blood sugar and cardiomyopathy. By-products of fatty acid processing build up in tissues, which also contributes to the signs and symptoms of malonyl-CoA decarboxylase deficiency.

Malonyl-CoA decarboxylase deficiency is inherited in an autosomal recessive pattern. This means the defective gene is located on an autosome, and two copies of the defective gene - one inherited from each parent - are required to be born with the disorder. The parents of a child with an autosomal recessive disorder both carry one copy of the defective gene, but are usually not affected by the disorder.

External links

Template:Lipidemias

Template:WH Template:WS